Frontiers | An Update on Protective Effectiveness of Immune Responses After Recovery From COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibits variable immunity responses among hosts based on symptom severity. Whether immunity in recovered individuals is effective for avoiding reinfection is poorly understood. Determination of immune memory status against SARS-CoV-2 helps identify reinfection risk and vaccine efficacy. Hence, after recovery from COVID-19, evaluation of protective effectiveness and durable immunity of prior disease could be significant. Recent reports described the dynamics of SARS-CoV-2 -specific humoral and cellular responses for more than six months in convalescent SARS-CoV-2 individuals. Given the current evidence, NK cell subpopulations, especially the memory-like NK cell subset, indicate a significant role in determining COVID-19 severity. Still, the information on the long-term NK cell immunity conferred by SARS-CoV-2 infection is scant. The evidence from vaccine clinical trials and observational studies indicates that hybrid natural/vaccine immunity to SARS-CoV-2 seems to be notably potent protection. We suggested the combination of plasma therapy from recovered donors and vaccination could be effective. This focused review aims to update the current information regarding immune correlates of COVID-19 recovery to understand better the probability of reinfection in COVID-19 infected cases that may serve as guides for ongoing vaccine strategy improvement.

Related Keywords

Qatar ,Umhlanga ,Eastern Cape ,South Africa ,Crawford ,Western Cape ,Iran ,Renji ,Henan ,China ,Shiraz ,Fars ,Makhado ,Limpopo ,Saudi Arabia ,Hubei ,Guangdong ,Cambridge ,Cambridgeshire ,United Kingdom ,Wuhan ,South Korea ,Oosthuysen ,Free State ,Saudi ,Han ,Yunbao Pan ,Paige Lawrence ,Zhengm Tim ,Cohen Tervaert ,Cullym Exosome ,Jernbom Falk ,Nasrin Shokrpour ,Shiraz University Of Medical Science ,Health Sci ,Terminal Differentiation Of Plasma Cells In Health ,Shiraz University Of Medical Sciences ,Development Of Clinical Research Nemazee Hospital ,S Specific Igg ,Natural Immunity ,Vaccine Immunity ,Shiraz University ,Medical Science ,Medical Sciences ,Clinical Research ,Nemazee Hospital ,Incomplete Adaptive Immunity ,With Different Disease ,Sci Total Environ ,Med Abstract ,Crossref Full Text ,B Cell Memory Response Over Time ,Clin Microbiol Infection ,Cell Response Detection Method Based ,Newly Identified Human ,Hubei Province ,Humoral Immunity ,Common Viral ,Antibody Immunity ,Igg Antibody Responses ,With Differing ,Sci China Life ,Protects Against Rechallenge ,Patients With ,See Protection ,Nat Rev Immunol ,Virus Shedding Patterns ,Fecal Specimens ,Patients Recovered From ,With Less Severe Manifestations ,May Not Develop Long Lasting Humoral ,Case Report From ,Reinfections Mean ,Infect Dis ,Protected From ,Front Med ,Humoral Response Correlates With Disease Severity ,Signal Transduction Targeted Ther ,Antibody Mediated Protection Against ,Reviews Immunology ,Specific Humoral ,Cellular Immunity ,Serological Assay ,Nat Med ,Human Single Domain Antibodies Against ,Host Microbe ,Emerging Viral ,Plos Med ,Neutralizing Fcr Mediated Antibody Functions ,Universal Influenza ,Front Immunol ,Use Multiple Receptors ,Center Host ,Intj Mol Sci ,Rev Immunol ,Induces Sustained Humoral Immune Responses ,Convalescent Patients Following Symptomatic ,Saliva Antibody Responses ,Sci Immunol ,Human Antibody Responses ,Receptor Binding Domain ,Immunological Assessment ,Memoryb Cell Subsets ,Saudij Biol Sci ,Antibody Responses ,Humoral Immune Response ,Circulating Follicular Helpert Cell Responses ,Recovered Patients With ,Cellular Immune Responses ,Nat Commun ,Mucosal Humoral Immunity Among ,Responses Against ,Biological Assessment ,Mild Versus Severe ,Immune Perturbations Associated With Severe ,Immune Profiling ,Reveals Distinct Immunotypes With Therapeutic ,Single Cell Atlas ,Peripheral Immune Response ,Patients With Severe ,Biol Sci ,Long Lived Humoral Immunity ,Terminal Differentiation ,Plasma Cells ,Immunol Rev ,Annu Rev Immunol ,Serum Antibody ,Immunological Memory Following Smallpox ,Memoryb Cell ,Long Lived Plasma ,Long Term Effects ,Booster Immunisation ,Antigen Specific Memory ,Long Termb Cell Memory ,Humans After Smallpox ,Bacillus Anthracis Protective Antigen ,Patients With Bioterrorism Related Cutaneous ,Decay Half Lives ,Relativistic Point Coupling ,Nucl Particle Phys ,Changes Followingb Lymphocyte Depletion Therapy ,Arthritis Rheumatism ,Targeted Therapy With Rituximab ,Patients With Rheumatoid ,New Englj Med ,Humoral Immunity Against ,Cell Rep Med ,Convalescent Individuals With Asymptomatic ,Transduct Target Ther ,Antiviral Lymphocytes ,Cell Mol Immunol ,Functional Exhaustion ,Patients With Coronavirus Disease ,Immune Response ,Patients With Coronavirus ,Clin Infect Dis ,New Strategy ,Humans With ,Cellular Insights Intot Cell ,Reverset Cell Exhaustion ,Restore Anti Tumor ,Adults Recovered From Mild ,Immunodominant Sites ,Structure Guided High Resolution ,Eight Months After ,Specifict Cells Exhibit Phenotypic Features ,Helper Function ,High Proliferation ,Low Risk ,Following Asymptomatic ,Intern Med ,Cytokine Storm ,Factors Determining ,Organ Dysfunction ,Multiple Organ Dysfunction ,Patients Infected With ,System Changes During ,Play Key Role ,Determining Disease ,Reinfection With ,Lancet Infect Dis ,Whole Genome ,Kime S ,Cell Population Is Prolonged ,Specific Immune Response ,Wangx M ,Wangw H ,Zhangs Y ,Exhaustion Checkpoint ,Cytokine Storms ,Hum Immunol ,Skewing Towards ,Killer Cell Dysfunction ,Its Role ,New Hope ,Unconventional Cytotoxic Mediators ,Front Cell ,Increased Inhibitory ,Associated With Emergence ,Omicron Variant ,Clin Invest ,Antibodies Against ,Boosters Induce Neutralizing Immunity Against ,Tabulated Summary ,Cellular Responses ,Vaccine Efficacy Against This ,Immunol Lett ,Sustained Cellular Immunity Against Wild Type ,Hemodialysis Patients Immunized With ,Doses Compared With ,Kidney Int ,Cell Reactivity ,Variant Is Preserved ,Most But Not All Prior Infected ,Omicron Variant From Previous ,Variants Exhibit Differential Infectivity ,Neutralization Resistance ,Cell Host Microbe ,Immunity After ,Vaccination Against ,Viral Immunol ,Robust Humoral Response ,Antibodies That Effectively Neutralize ,Reactive Neutralizing Antibody Responses Elicited ,Memoryb Cell Responses ,Recovered Individuals After ,Variants After First Vaccine ,Enhanced Neutralizing Breadth ,Adaptive Immune Response Against ,Based Candidates Move Into ,Nat Rev Drug Discovery ,Therapeutic Approaches ,Mol Med ,Recovered ,Hybrid Immunity ,Vaccination ,Covid 19 ,